Anteotech Ltd
ASX:ADO

Watchlist Manager
Anteotech Ltd Logo
Anteotech Ltd
ASX:ADO
Watchlist
Price: 0.019 AUD 5.56% Market Closed
Market Cap: 52m AUD
Have any thoughts about
Anteotech Ltd?
Write Note

Anteotech Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Anteotech Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Anteotech Ltd
ASX:ADO
Other Liabilities
AU$575.2k
CAGR 3-Years
7%
CAGR 5-Years
25%
CAGR 10-Years
22%
Proteomics International Laboratories Ltd
ASX:PIQ
Other Liabilities
AU$499.9k
CAGR 3-Years
33%
CAGR 5-Years
49%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Other Liabilities
AU$387k
CAGR 3-Years
-13%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Other Liabilities
AU$12m
CAGR 3-Years
-11%
CAGR 5-Years
-11%
CAGR 10-Years
13%
Genetic Signatures Ltd
ASX:GSS
Other Liabilities
AU$121k
CAGR 3-Years
89%
CAGR 5-Years
44%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Other Liabilities
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Anteotech Ltd
Glance View

Market Cap
47.3m AUD
Industry
Life Sciences Tools & Services

AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.

ADO Intrinsic Value
0.002 AUD
Overvaluation 91%
Intrinsic Value
Price

See Also

What is Anteotech Ltd's Other Liabilities?
Other Liabilities
575.2k AUD

Based on the financial report for Jun 30, 2024, Anteotech Ltd's Other Liabilities amounts to 575.2k AUD.

What is Anteotech Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
22%

Over the last year, the Other Liabilities growth was 10%. The average annual Other Liabilities growth rates for Anteotech Ltd have been 7% over the past three years , 25% over the past five years , and 22% over the past ten years .

Back to Top